Duke Kidney

We are so happy to start the new year and welcome new fellows, celebrate graduates, and see the transition from first year to second year. #NephFellow

RT @DanEdmonston: @DukeKidney Don’t forget this gem!

RT @JCI_insight: Sunday Read💫: A novel axis that can fine-tune the immune response to glomerular and tubule cell damage: Jamie R. Privratsky @JamiePrivratsky & team @DukeKidney @Duke_Anesthesia identify a novel myeloid cell-endothelial cell immunoregulatory axis, supporting a model whereby myeloid IL-1R1 activity constrains ER stress–mediated EBI3/IL27 secretion, thereby attenuating type I IFN expression in kidney endothelial cells and ameliorating autoimmune nephritis. The figure shows anti-IFNAR1 therapy abrogates kidney injury after NTS nephritis in mice lacking IL-1R1 specifically in myeloid cells (bottom); littermate controls (top). #AKI #Nephrology #kidney #macrophage

Duke Kidney representing at ASN Kidney Week in Denver, CO

Congrats to #NephFaculty Dr Sparks who will give the Burton D. Rose, MD, Endowed Lectureship at ASN Kidney Week 2026 in Denver CO, Oct 22nd “Formulating a Dialysis Access Curriculum: Bridging the Gap in Education and Training”

RT @JCI_insight: Presenting a novel axis that can fine-tune the immune response to glomerular and tubule cell damage: Jamie R. Privratsky @JamiePrivratsky & team @DukeKidney @Duke_Anesthesia identify a novel myeloid cell-endothelial cell immunoregulatory axis, supporting a model whereby myeloid IL-1R1 activity constrains ER stress–mediated EBI3/IL27 secretion, thereby attenuating type I IFN expression in kidney endothelial cells and ameliorating autoimmune nephritis. The figure shows anti-IFNAR1 therapy abrogates kidney injury after NTS nephritis in mice lacking IL-1R1 specifically in myeloid cells (bottom); littermate controls (top). #AKI #Nephrology #kidney #macrophage

#NephFaculty Dr Steve Crowley chairs the AHA #Hypertension26 meeting in Arlington, VA

#FellowLife 1st year: Dr. Ethan Witt Residency: Oregon Health & Science University Med School: University of Vermont

#FellowLife 2nd year: Dr. Mike Tabet Residency: University of Vermont Med School: Louisiana State University in New Orleans

New from #NephFaculty Dr Ortiz-Melo and Dr Coffman in JCI Insight Proximal tubule ACE2 mediates early responses to hypertension by regulating intrarenal RAS and sodium homeostasis

New form #NephFaculty Dr Rasheeda Hall and colleagues in Nature Reviews Nephrology Recommendations for the management of frailty in chronic kidney disease: a consensus report

#FellowLife 1st year: Dr. Josh Daum Residency (chief resident): Mayo Clinic – Rochester, MN Med School: Mayo Clinic Alix School of Medicine – Phoenix, AZ

#FellowLife 1st year: Dr. Mason Kalada Residency: Wake Forest Med School: East Tennessee State University

Congrats to #NephFaculty Dr Matthew Sinclair on his K23 NIH NIDDK grant titled #NephForward “Promoting Evidence-Based Chronic Kidney Disease Care among Hispanics/Latinos with Type 2 Diabetes”

Congrats to #NephFaculty Dr Anika Lucas on her K23 NIH NIDDK grant titled #NephForward “Psychosocial Stress and the Role of Kidney Disease”

Welcome Sydney Hege, PharmDClinical Pharmacist Practitionerto Duke Nephrology She will see patients in our ambulatory clinics focusing on Kidney GDMT and CKM Syndrome

#NephFaculty Dr Anna Strasma featured in the Duke Climate Commitment Impact Report 2026 Early Warning Systems Within a Warming World: Extreme Heat and Human Health

#FellowLife 2nd year (chief fellow): Dr. Samiddhi Weerasiri Residency: Mayo Clinic – Rochester Med School: Virginia Commonwealth University

#FellowLife 1st year: Dr. Chelsea Smith Residency: University of Kansas Med School: University of Arkansas for Medical Sciences

Applications are open for the 2027 NephSIM Nephrons & NKF Program, a 6-month virtual nephrology experience designed for medical students and residents

#FellowLife 2nd year: Dr. Chrystel Pawly Residency: Yale-Waterbury Med School: Lebanese American University (Byblos, Lebanon)